Biopharmaceutical services provider, Parexel, has appointed Jamie Macdonald as its chief executive officer (CEO), a role that will see him succeed Josef von Rickenbach.
Macdonald previously led INC Research, now known as Syneos Health, for several years first as CEO and most recently as vice chairman.
He has also served as senior vice president and head of global project management at Quintiles, now IQVIA.
Macdonald said: “As a trail blazer in the biopharmaceutical services industry, the company enjoys well-deserved recognition as having the kind of deep therapeutic and functional expertise, global reach and innovative capability to continue its leadership.
“I am humbled to have the opportunity to build on this legacy and look forward to continued growth and excellence for Parexel.”